1. Home
  2. PROF vs GOSS Comparison

PROF vs GOSS Comparison

Compare PROF & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROF
  • GOSS
  • Stock Information
  • Founded
  • PROF N/A
  • GOSS 2015
  • Country
  • PROF Canada
  • GOSS United States
  • Employees
  • PROF N/A
  • GOSS N/A
  • Industry
  • PROF Medical/Dental Instruments
  • GOSS Biotechnology: Pharmaceutical Preparations
  • Sector
  • PROF Health Care
  • GOSS Health Care
  • Exchange
  • PROF Nasdaq
  • GOSS Nasdaq
  • Market Cap
  • PROF 186.3M
  • GOSS 212.9M
  • IPO Year
  • PROF N/A
  • GOSS 2019
  • Fundamental
  • Price
  • PROF $7.55
  • GOSS $0.70
  • Analyst Decision
  • PROF Strong Buy
  • GOSS Strong Buy
  • Analyst Count
  • PROF 2
  • GOSS 5
  • Target Price
  • PROF $11.40
  • GOSS $9.20
  • AVG Volume (30 Days)
  • PROF 45.3K
  • GOSS 966.8K
  • Earning Date
  • PROF 11-07-2024
  • GOSS 11-07-2024
  • Dividend Yield
  • PROF N/A
  • GOSS N/A
  • EPS Growth
  • PROF N/A
  • GOSS N/A
  • EPS
  • PROF N/A
  • GOSS N/A
  • Revenue
  • PROF $8,984,000.00
  • GOSS $105,322,000.00
  • Revenue This Year
  • PROF $56.11
  • GOSS N/A
  • Revenue Next Year
  • PROF $171.96
  • GOSS N/A
  • P/E Ratio
  • PROF N/A
  • GOSS N/A
  • Revenue Growth
  • PROF 39.35
  • GOSS N/A
  • 52 Week Low
  • PROF $7.11
  • GOSS $0.50
  • 52 Week High
  • PROF $11.42
  • GOSS $1.60
  • Technical
  • Relative Strength Index (RSI)
  • PROF 44.16
  • GOSS 25.81
  • Support Level
  • PROF $7.40
  • GOSS $0.66
  • Resistance Level
  • PROF $8.22
  • GOSS $0.92
  • Average True Range (ATR)
  • PROF 0.50
  • GOSS 0.05
  • MACD
  • PROF -0.06
  • GOSS -0.02
  • Stochastic Oscillator
  • PROF 8.32
  • GOSS 13.23

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: